Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aztreonam

B A Cunha1

  • 1Infectious Disease Division, Winthrop-University Hospital, Mineola, New York.

Urology
|March 1, 1993
PubMed
Summary

Aztreonam, a unique monobactam antibiotic, effectively treats gram-negative bacterial infections, particularly in complicated urinary tract infections. It offers a safe alternative for patients with penicillin allergies, avoiding aminoglycoside toxicity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Similarities and differences between doxycycline and minocycline: clinical and antimicrobial stewardship considerations.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2017
Same author

Nitrofurantoin safety and effectiveness in treating acute uncomplicated cystitis (AUC) in hospitalized adults with renal insufficiency: antibiotic stewardship implications.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2017
Same author

Viral influenza-like illnesses: dynamic interrelationships during the 2015-2016 influenza season in hospitalized patients.

The Journal of hospital infection·2017
Same author

Editor's Mail.

Postgraduate medicine·2016
Same author

Are atypical lymphocytes present with viral influenza-like illnesses (ILIs) in hospitalized adults?

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2016
Same author

Problems+Solutions.

Postgraduate medicine·2016

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Urology

Background:

  • Aztreonam is the first clinically available monobactam antibiotic.
  • Beta-lactam antibiotics exhibit varied spectra of activity.
  • Gram-negative aerobic bacteria are a significant cause of urologic infections.

Purpose of the Study:

  • To review the clinical utility of aztreonam in treating complicated urinary tract infections.
  • To highlight aztreonam's safety profile, especially in penicillin-allergic patients.
  • To compare aztreonam's efficacy and safety with other antibiotic classes.

Main Methods:

  • Review of clinical experience and published data on aztreonam use.
  • Analysis of aztreonam's spectrum of activity against gram-negative bacteria.
  • Evaluation of safety data, including ototoxicity and nephrotoxicity.

Main Results:

  • Aztreonam demonstrates exclusive activity against gram-negative aerobic bacteria.
  • Clinical data support its use in severe or complicated urologic infections.
  • Aztreonam is safe for patients with a history of penicillin allergy.
  • Its safety profile is favorable compared to aminoglycosides, lacking ototoxicity and nephrotoxicity.

Conclusions:

  • Aztreonam is a safe and effective monobactam antibiotic for treating gram-negative bacterial infections.
  • It is a rational therapeutic choice for systemic urinary tract infections caused by susceptible organisms.
  • Aztreonam provides an alternative for patients unable to tolerate other antibiotic classes, such as aminoglycosides.

Related Experiment Videos